Public procurement of health technologies in Greece in an era of economic crisis

Kastanioti, Catherine; Kontodimopoulos, Nick; Stasinopoulos, Dionysis; Kapetaneas, Nikolaos; Polyzos, Nikolaos

doi:10.1016/j.healthpol.2012.03.015

Cited by 76 publications

(56 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On average, the centralized procurer pays about 20-23% (and the hybrid procurer pays about 7-9%) less than the decentralized agency. Such figures seem quite reasonable, with price reductions similar to the ones found by BANDIERA et al (2009) andKASTANIOTI et al (2013) for goods and services procured through the Italian and the Greek central agencies, respectively.…”

Section: Impact Of Centralization On Pharmaceutical Procurement Pricessupporting

confidence: 71%

“…KARJALAINEN (2011), focusing on Finnish government data, estimated the potential price savings by comparing the prices paid by the centralized agency with the market prices for two selected products and found savings of around 8% for toner cartridges and around 37% for specific flight tickets (with very flexible contracts and cancellation terms). In a recent paper, KASTANIOTI et al (2013) found that the establishment in 2008 of the Health Procurement Committee in Greece had the effect of unifying tenders, and prices reduced overall by 10%. Moreover, framework agreement tenders for selected medical devices (prostheses, pacemakers, dialysis systems, lenses) and e-auctions for 32 active substances resulted in an abatement of purchasing prices in the order of 30-75% and 57%, respectively.…”

Section: Centralization Versus Decentrali-zation Of Procurementmentioning

confidence: 99%

See 1 more Smart Citation

The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption

Baldi¹,

Vannoni

2015

Regional Studies

View full text Add to dashboard Cite

BALDI S. and VANNONI D. The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption, Regional Studies. This paper deals with the open issue regarding centralized versus decentralized public procurement strategy. Using a unique dataset on tender prices of selected drugs for hospital usage provided by a sample of 52 Italian local health service providers (aziende sanitarie locali -ASLs) between 2009 and 2012, the paper tests which procurement system (centralized, decentralized or hybrid) performs better. Controlling for several covariates, including measures of institutional quality and corruption, it finds that centralized and hybrid procurers pay lower prices than decentralized units. Moreover, the results show that in areas in which institutional quality is lower or corruption is higher, the effect of centralization in terms of negotiating lower prices is much stronger, with savings of up to 60% of the price paid by ASLs that procure independently. Public procurementCentralization Decentralization Pharmaceutical spending BALDI S. and VANNONI D. 集中化对药品採购价格的影响：制度质量与贪腐的角色，区域研究。本文处理有关集中化与去中心化的公共採购策略之开放议题。本文运用五十二个意大利地方健康服务供给者(aziende sanitarie localiASLs)样本所提供的2009年至2012年医院选定用药的投标价格之特殊数据集，测试何种採购系统(集中化、去中心化或混合式)表现较佳。本研究控制包含制度质量与贪腐的测量之若干共变量后，发现较去中心化而言，集中式和混合式的採购每单位支付的价格较低。此外，研究结果显示，在制度质量较低或贪腐较为严重的地区中，集中化在协商较低价格方面的影响更为显着，且最多节省了ASLs各自採购所支付的价格的百分之六十。公共採购集中化去中心化药品花费 BALDI S. et VANNONI D. L'impact de la centralisation sur le prix d'offre des produits pharmaceutiques: le rôle de la qualité institutionnelle et de la corruption, Regional Studies. Ce présent article cherche à aborder la question ouverte de la centralisation contre la décentralisation des commandes publiques. À partir d'un ensemble de données unique sur les prix figurant dans les appels d'offre pour une série de médicaments à l'usage des hôpitaux et provenant d'un échantillon de 52 prestataires de services de santé locaux (aziende sanitarie locali -ASL) entre 2009 et 2012, l'article cherche à tester lequel des systèmes d'approvisionnement (centralisé, décentralisé ou hybride) donne les meilleurs résultats. Tenant compte de plusieurs covariables, y compris des mesures de la qualité institutionnelle et de la corruption, il s'avère que les acheteurs centralisés et hybrides paient des prix inférieurs que ne le paient les unités décentralisées. En outre, les résultats indiquent que dans les zones où la qualité institutionnelle est plus faible ou la corruption est plus forte, l'effet de la centralisation, en termes de la négociation des prix, est beaucoup plus forte, dont les économies se chiffrent à jusqu'à 60% du prix payé par les ASL qui s'approvisionnent indépendamment. Commandes publiques Centralisation Décentralisation Dépenses de produits pharmaceutiques BALDI S. und VANNONI D. Auswirkung von Zentralisierung auf die Preise bei der pharmazeutischen Auftragsvergabe: die Rolle der institutionellen Qualität und Korruption, Regional Studies. In diesem Beitrag wird die offene Frage einer zentralisierten...

show abstract

Section: Impact Of Centralization On Pharmaceutical Procurement Pricessupporting

confidence: 71%

Section: Centralization Versus Decentrali-zation Of Procurementmentioning

confidence: 99%

The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption

Baldi¹,

Vannoni

2015

Regional Studies

View full text Add to dashboard Cite

show abstract

“…A reform to public procurement developed by the Greek government under the aegis of the troika, has streamlined a previously inefficient system. 23 It clearly makes sense to treat patients outside hospitals where this is appropriate. However, that assumes that there are alternative facilities available, which in many southern European countries where social care has largely been undertaken by families is unlikely to be the case.…”

Section: Discussionmentioning

confidence: 99%

Austerity: a failed experiment on the people of Europe

et al. 2012

View full text Add to dashboard Cite

-Many governments in Europe, either of their own volition or at the behest of the international financial institutions, have adopted stringent austerity policies in response to the financial crisis. By contrast, the USA launched a financial stimulus. The results of these experiments are now clear: the American economy is growing and those European countries adopting austerity, including the UK, Ireland, Greece, Portugal and Spain, are stagnating and struggling to repay rising debts. An initial recovery in the UK was halted once austerity measures hit. However, austerity has been not only an economic failure, but also a health failure, with increasing numbers of suicides and, where cuts in health budgets are being imposed, increasing numbers of people being unable to access care. Yet their stories remain largely untold. Here, we argue that there is an alternative to austerity, but that ideology is triumphing over evidence. Our paper was written to contribute to discussions among health policy leaders in Europe that will take place at the 15th European Health Forum at Gastein in October 2012, as its theme 'Crisis and Opportunity -Health in an Age of Austerity'.

show abstract

“…REPÈRES médicaux et jusqu'à 80 % sur quelques médicaments [22]. Selon les accords signés avec la Troika, 45 % des biens médicaux devraient être achetés selon cette procédure en 2014 et 60 % en 2015 [5].…”

Section: Faits Et Chiffresunclassified

L’impact de la crise économique sur les systèmes de santé des pays de l’OCDE

Paris

2014

Med Sci (Paris)

View full text Add to dashboard Cite

Public procurement of health technologies in Greece in an era of economic crisis

Cited by 76 publications

References 13 publications

The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption

The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption

Austerity: a failed experiment on the people of Europe

L’impact de la crise économique sur les systèmes de santé des pays de l’OCDE

Contact Info

Product

Resources

About